29 May 2024 | Wednesday | News
Stryker a global leader in medical technologies, announced that the first surgeries using the Gamma4 Hip Fracture Nailing System in Europe were completed at the Luzerner Kantonsspital LUKS, at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, and at Les Hôpitaux Universitaires de Strasbourg in France. Stryker will debut the system during a live broadcast event in Germany, on June 4, 2024, highlighting key insights and case discussions.
The Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker's SOMA database, which includes over 37,000 3D bone models generated from CT scans. The system received CE certification in November 2023 and has been utilized in over 25,000 cases in North America and Japan.
“This moment marks a significant milestone, as the Gamma4 Hip Fracture Nailing System enters the European market, following the successful launch in the United States,” said Markus Ochs, vice president and general manager of Stryker’s European Trauma & Extremities business. “This system represents Stryker’s unwavering commitment to innovation and excellence in providing advanced medical solutions, empowering surgeons worldwide with options designed to streamline operative flow and improve procedural efficiency.”
The first surgeries in Europe were completed by:
When asked about their experience, the Swiss surgeons agreed that Gamma4 allows for a tailored approach to each patient's unique anatomy and offers several key features to enhance surgical outcomes. The system's intuitive instrumentation streamlines procedures and reduces the number of surgical steps required. The surgeons noted the accuracy of the implant fit and the overall quality of the instruments.
Since these initial use cases, more than 35 additional surgeries utilizing the Gamma4 system have been completed in France, Italy, the UK, and Switzerland.
During the live broadcast event scheduled for June 4, 2024, 17:30 CET, Stryker will share key insights and a deep dive into the Gamma4 engineering philosophy. Esteemed faculty, including Professor Dr. Gerhard Schmidmaier from University Hospital Heidelberg, PD Dr. Arvind G. Von Keudell from University Hospital Copenhagen, and Professor Dr. Julio de Caso Rodríguez from Hospital de la Santa Creu i Sant Pau in Barcelona, will lead in-depth case discussions on trauma surgery.
© 2024 Biopharma Boardroom. All Rights Reserved.